Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study

Nour El Hoda S. Ismael; Samar A. El Sheikh; Suzan M. Talaat; Eman M. Salem

doi:10.3889/oamjms.2017.003

Authors

Nour El Hoda S. Ismael Faculty of Medicine, Cairo University, Cairo
Samar A. El Sheikh Faculty of Medicine, Cairo University, Cairo
Suzan M. Talaat Ahmed Maher Teaching Hospital, Cairo
Eman M. Salem Ahmed Maher Teaching Hospital, Cairo

DOI:

https://doi.org/10.3889/oamjms.2017.003

Keywords:

Colorectal cancer, Immunohistochemistry, Lynch Syndrome, Microsatellite instability, Mismatch repair proteins

Abstract

BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide. Microsatellite instability (MSI) is detected in about 15% of all colorectal cancers. CRC with MSI has particular characteristics such as improved survival rates and better prognosis. They also have a distinct sensitivity to the action of chemotherapy.

AIM: The aim of the study was to detect microsatellite instability in a cohort of colorectal cancer Egyptian patients using the immunohistochemical expression of mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2).

MATERIAL AND METHODS: Cases were divided into Microsatellite stable (MSS), Microsatellite unstable low (MSI-L) and Microsatellite unstable high (MSI-H). This Microsatellite stability status was correlated with different clinicopathological parameters.

RESULTS: There was a statistically significant correlation between the age of cases, tumor site & grade and the microsatellite stability status. There was no statistically significant correlation between the gender of patients, tumor subtype, stage, mucoid change, necrosis, tumor borders, lymphocytic response, lymphovascular emboli and the microsatellite stability status.

CONCLUSION: Testing for MSI should be done for all colorectal cancer patients, especially those younger than 50 years old, right sided and high-grade CRCs.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010; 375: 1030â€“1047. https://doi.org/10.1016/S0140-6736(10)60353-4 DOI: https://doi.org/10.1016/S0140-6736(10)60353-4

Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61 (2): 69â€“90. https://doi.org/10.3322/caac.20107 DOI: https://doi.org/10.3322/caac.20107

Lo AC, Soliman A, Khaled HM, et al. Lifestyle, Occupational, and Reproductive Factors and Risk of Colorectal Cancer. Dis Colon Rectum. 2010; 53(5): 830â€“837. https://doi.org/10.1007/DCR.0b013e3181d320b1 PMid:20389219 PMCid:PMC3223860 DOI: https://doi.org/10.1007/DCR.0b013e3181d320b1

Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010; 31(2): 31-8. PMid:20498827 PMCid:PMC2874430

Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6): 2073-87. https://doi.org/10.1053/j.gastro.2009.12.064 PMid:20420947 PMCid:PMC3037515 DOI: https://doi.org/10.1053/j.gastro.2009.12.064

Vilar E, Gruber SB. Microsatellite instability in colorectal cancer e the stable evidence. Nat Rev Clin Oncol. 2010; 7(3): 153-62. https://doi.org/10.1038/nrclinonc.2009.237 PMid:20142816 PMCid:PMC3427139 DOI: https://doi.org/10.1038/nrclinonc.2009.237

Lynch HT, Snyder CL, Shaw TG, et al. Milestones of Lynch syndrome: 1895â€“2015. Natural reviews Cancer. 2015; 15: 181-194. https://doi.org/10.1038/nrc3878 PMid:25673086 DOI: https://doi.org/10.1038/nrc3878

Bonadona V, BonaÃ¯ti B, Olschwang S, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011; 305:2304â€“2310. https://doi.org/10.1001/jama.2011.743 PMid:21642682 DOI: https://doi.org/10.1001/jama.2011.743

Heald B, Church J, Plesec T, et al. Detecting and managing hereditary colorectal cancer syndromes in your practice. Cleveland clinic journal of medicine. 2012; 79 (11): 787-796. https://doi.org/10.3949/ccjm.79a.11165 PMid:23125329 DOI: https://doi.org/10.3949/ccjm.79a.11165

Riddell R, Jain D, Bernstein CN, et al. Gastrointestinal pathology and its clinical implications. Philadelphia: Lippincott Williams & Wilkins, 2014: 1327-1523.

Deng G, Bell I, Crawley S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004; 10: 191â€“195. https://doi.org/10.1158/1078-0432.CCR-1118-3 PMid:14734469 DOI: https://doi.org/10.1158/1078-0432.CCR-1118-3

Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006;7(5): 335â€“346. https://doi.org/10.1038/nrm1907 PMid:16612326 DOI: https://doi.org/10.1038/nrm1907

Raut CP, Pawlik TM, Rodriguez-Bigas MA. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat Res. 2004; 568(2): 275-82. https://doi.org/10.1016/j.mrfmmm.2004.05.025 PMid:15542114 DOI: https://doi.org/10.1016/j.mrfmmm.2004.05.025

Jung SH, Kim SH and Kim JH. Prognostic impact of microsatellite instability in colorectal cancer presenting with mucinous, signet -Ring, and poorly differentiated cells. Ann Coloproctol. 2016; 32(2): 58â€“65. https://doi.org/10.3393/ac.2016.32.2.58 PMid:27218096 PMCid:PMC4865466 DOI: https://doi.org/10.3393/ac.2016.32.2.58

Guastadisegni C, Colafranceschi M, Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta analysis of colorectal cancer survival data. Eur J Cancer. 2010; 46(15): 2788-98. https://doi.org/10.1016/j.ejca.2010.05.009 PMid:20627535 DOI: https://doi.org/10.1016/j.ejca.2010.05.009

Malesci A, Laghi L, Bianchi P, et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res. 2007; 13(13):3831-9. https://doi.org/10.1158/1078-0432.CCR-07-0366 PMid:17606714 DOI: https://doi.org/10.1158/1078-0432.CCR-07-0366

Yuan L, Chi Y, Chen W, et al. Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency. Int J Clin Exp Med. 2015; 8(11): 20988-21000. PMid:26885030 PMCid:PMC4723875

Rustgi AK.The genetics of hereditary colon cancer. Genes Dev. 2016; 21: 2525-2538. https://doi.org/10.1101/gad.1593107 PMid:17938238 DOI: https://doi.org/10.1101/gad.1593107

Gadoa A, Ebeidb B, Abdelmohsen A, et al. Colorectal cancer in Egypt is commoner in young people: Is this cause for alarm? Alexandria Journal of Medicine. 2014; 50 (3): 197â€“201. https://doi.org/10.1016/j.ajme.2013.03.003 DOI: https://doi.org/10.1016/j.ajme.2013.03.003

Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008; 135(4):1079-99. https://doi.org/10.1053/j.gastro.2008.07.076 PMid:18773902 PMCid:PMC2866182 DOI: https://doi.org/10.1053/j.gastro.2008.07.076

Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998; 58(15):3455-60. PMid:9699680

Huang Y, Yuan Y, Wei-ting GE, et al. Comparative features of colorectal and gastric cancers with microsatellite instability in Chinese patients. Biomed & Biotechnol. 2010;11(9): 647-653. https://doi.org/10.1631/jzus.b1000198 DOI: https://doi.org/10.1631/jzus.B1000198

Jenkins MA, Hayashi S, O'shea A, et al. Pathology features in Bethesda Guidelines predict colorectal cancer microsatellite instability: A population-based study. Gastroenterol. 2007; 133: 48â€“56. https://doi.org/10.1053/j.gastro.2007.04.044 PMid:17631130 PMCid:PMC2933045 DOI: https://doi.org/10.1053/j.gastro.2007.04.044

Greenson JK, Huang SC, Herron C, et al. Pathologic Predictors of Microsatellite Instability in Colorectal Cancer. Am J Surg Pathol. 2009; 33(1): 126â€“133. https://doi.org/10.1097/PAS.0b013e31817ec2b1 PMid:18830122 PMCid:PMC3500028 DOI: https://doi.org/10.1097/PAS.0b013e31817ec2b1

Faghani M, Asl SF, Ghanaei FM, et al. The Correlation between Microsatellite Instability and the Features of Sporadic Colorectal Cancer in the North Part of Iran. Gastroenterology Research and Practice. 2012; 2012:1-6. https://doi.org/10.1155/2012/756263 PMid:23213329 PMCid:PMC3507153 DOI: https://doi.org/10.1155/2012/756263

Frey DM, Droeser RA, Viehl CT, et al. High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patient. International Journal of Cancer. 2010;126(11): 2635-2643. https://doi.org/10.1002/ijc.24989 DOI: https://doi.org/10.1002/ijc.24989

Yearsley M, Hampel H, Lehman A, et al. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Human pathology. 2006;37 (7): 831â€“838. https://doi.org/10.1016/j.humpath.2006.02.009 PMid:16784982 DOI: https://doi.org/10.1016/j.humpath.2006.02.009

Joel KG, Joseph DB, Ofer BZ, et al. Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well-Differentiated and Focally Mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. American Journal of Surgical Pathology. 2003; 27(5): 563-57. https://doi.org/10.1097/00000478-200305000-00001 DOI: https://doi.org/10.1097/00000478-200305000-00001

Setaffy L, Langner C. Microsatellite instability in colorectal cancer:clinicopathological significance. Pol J Pathol. 2015; 66(3):203-18. https://doi.org/10.5114/pjp.2015.54953 PMid:26619098 DOI: https://doi.org/10.5114/pjp.2015.54953